Index
1 Market Overview of Progenitor Cell Product
1.1 Progenitor Cell Product Market Overview
1.1.1 Progenitor Cell Product Product Scope
1.1.2 Progenitor Cell Product Market Status and Outlook
1.2 Global Progenitor Cell Product Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Progenitor Cell Product Market Size by Region (2018-2029)
1.4 Global Progenitor Cell Product Historic Market Size by Region (2018-2023)
1.5 Global Progenitor Cell Product Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Progenitor Cell Product Market Size (2018-2029)
1.6.1 North America Progenitor Cell Product Market Size (2018-2029)
1.6.2 Europe Progenitor Cell Product Market Size (2018-2029)
1.6.3 Asia-Pacific Progenitor Cell Product Market Size (2018-2029)
1.6.4 Latin America Progenitor Cell Product Market Size (2018-2029)
1.6.5 Middle East & Africa Progenitor Cell Product Market Size (2018-2029)
2 Progenitor Cell Product Market by Type
2.1 Introduction
2.1.1 Pancreatic progenitor cells
2.1.2 Cardiac Progenitor Cells
2.1.3 Intermediate progenitor cells
2.1.4 Neural progenitor cells (NPCs)
2.1.5 Endothelial progenitor cells (EPC)
2.1.6 Others
2.2 Global Progenitor Cell Product Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Progenitor Cell Product Historic Market Size by Type (2018-2023)
2.2.2 Global Progenitor Cell Product Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Progenitor Cell Product Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Progenitor Cell Product Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Progenitor Cell Product Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Progenitor Cell Product Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Progenitor Cell Product Revenue Breakdown by Type (2018-2029)
3 Progenitor Cell Product Market Overview by Application
3.1 Introduction
3.1.1 Medical care
3.1.2 Hospital
3.1.3 Laboratory
3.2 Global Progenitor Cell Product Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Progenitor Cell Product Historic Market Size by Application (2018-2023)
3.2.2 Global Progenitor Cell Product Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Progenitor Cell Product Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Progenitor Cell Product Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Progenitor Cell Product Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Progenitor Cell Product Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Progenitor Cell Product Revenue Breakdown by Application (2018-2029)
4 Progenitor Cell Product Competition Analysis by Players
4.1 Global Progenitor Cell Product Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Progenitor Cell Product as of 2022)
4.3 Date of Key Players Enter into Progenitor Cell Product Market
4.4 Global Top Players Progenitor Cell Product Headquarters and Area Served
4.5 Key Players Progenitor Cell Product Product Solution and Service
4.6 Competitive Status
4.6.1 Progenitor Cell Product Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 NeuroNova AB
5.1.1 NeuroNova AB Profile
5.1.2 NeuroNova AB Main Business
5.1.3 NeuroNova AB Progenitor Cell Product Products, Services and Solutions
5.1.4 NeuroNova AB Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.1.5 NeuroNova AB Recent Developments
5.2 StemCells
5.2.1 StemCells Profile
5.2.2 StemCells Main Business
5.2.3 StemCells Progenitor Cell Product Products, Services and Solutions
5.2.4 StemCells Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.2.5 StemCells Recent Developments
5.3 ReNeuron Limited
5.3.1 ReNeuron Limited Profile
5.3.2 ReNeuron Limited Main Business
5.3.3 ReNeuron Limited Progenitor Cell Product Products, Services and Solutions
5.3.4 ReNeuron Limited Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.3.5 Asterias Biotherapeutics Recent Developments
5.4 Asterias Biotherapeutics
5.4.1 Asterias Biotherapeutics Profile
5.4.2 Asterias Biotherapeutics Main Business
5.4.3 Asterias Biotherapeutics Progenitor Cell Product Products, Services and Solutions
5.4.4 Asterias Biotherapeutics Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.4.5 Asterias Biotherapeutics Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Progenitor Cell Product Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 STEMCELL Technologies
5.6.1 STEMCELL Technologies Profile
5.6.2 STEMCELL Technologies Main Business
5.6.3 STEMCELL Technologies Progenitor Cell Product Products, Services and Solutions
5.6.4 STEMCELL Technologies Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.6.5 STEMCELL Technologies Recent Developments
5.7 Axol Bio
5.7.1 Axol Bio Profile
5.7.2 Axol Bio Main Business
5.7.3 Axol Bio Progenitor Cell Product Products, Services and Solutions
5.7.4 Axol Bio Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.7.5 Axol Bio Recent Developments
5.8 R&D Systems
5.8.1 R&D Systems Profile
5.8.2 R&D Systems Main Business
5.8.3 R&D Systems Progenitor Cell Product Products, Services and Solutions
5.8.4 R&D Systems Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.8.5 R&D Systems Recent Developments
5.9 Lonza
5.9.1 Lonza Profile
5.9.2 Lonza Main Business
5.9.3 Lonza Progenitor Cell Product Products, Services and Solutions
5.9.4 Lonza Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.9.5 Lonza Recent Developments
5.10 ATCC
5.10.1 ATCC Profile
5.10.2 ATCC Main Business
5.10.3 ATCC Progenitor Cell Product Products, Services and Solutions
5.10.4 ATCC Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.10.5 ATCC Recent Developments
5.11 Irvine Scientific
5.11.1 Irvine Scientific Profile
5.11.2 Irvine Scientific Main Business
5.11.3 Irvine Scientific Progenitor Cell Product Products, Services and Solutions
5.11.4 Irvine Scientific Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.11.5 Irvine Scientific Recent Developments
5.12 CDI
5.12.1 CDI Profile
5.12.2 CDI Main Business
5.12.3 CDI Progenitor Cell Product Products, Services and Solutions
5.12.4 CDI Progenitor Cell Product Revenue (US$ Million) & (2018-2023)
5.12.5 CDI Recent Developments
6 North America
6.1 North America Progenitor Cell Product Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Progenitor Cell Product Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Progenitor Cell Product Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Progenitor Cell Product Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Progenitor Cell Product Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Progenitor Cell Product Market Dynamics
11.1 Progenitor Cell Product Industry Trends
11.2 Progenitor Cell Product Market Drivers
11.3 Progenitor Cell Product Market Challenges
11.4 Progenitor Cell Product Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List